As many as 1 in 5 people won't lose weight with GLP-1 drugs, experts say

Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them.

The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost.

For Griffin, the hardest part of using the new drugs wasn't access. It was finding out that the much-hyped medications didn't really work for her.